Healthcare Development & Innovation Group (HDIG) notes that Medicare is implementing national coverage for qualifying non-invasive colorectal cancer biomarker screening tests using CPT 0421U with coinsurance and deductible waived.
Published
Signal category
Legal & Regulatory
Quote
“Medicare is implementing national coverage for qualifying non-invasive colorectal cancer biomarker screening tests.”
— Healthcare Development & Innovation Group (HDIG) team
Company
Healthcare Development & Innovation Group (HDIG)
The most Comprehensive resource for Healthcare Innovation
- Industry
- Venture Capital and Private Equity Principals
- Location
- Columbus, US
- Company size
- 5 employees
HDIG Search, HDIG Partnerships/Consult, HDIG Ventues HDIG was formed to help make innovation in healthcare more efficient by improving access to information and creating an ecosystem to foster targeted connections. Our database brings together the innovators, capital providers and healthcare providers in the easiest to use, most comprehensive searchable platform anywhere. Our Paid Pilot Program pays hospitals for running pilots for startups. Our Reverse Studio helps hospitals turn laggard projects from an expense to equity. Founded in 2021, HDIG is headquartered in Columbus OH.
Founded 2021